Literature DB >> 20037130

Comparison of the added value of contrast-enhanced 3D fluid-attenuated inversion recovery and magnetization-prepared rapid acquisition of gradient echo sequences in relation to conventional postcontrast T1-weighted images for the evaluation of leptomeningeal diseases at 3T.

H Fukuoka1, T Hirai, T Okuda, Y Shigematsu, A Sasao, E Kimura, T Hirano, S Yano, R Murakami, Y Yamashita.   

Abstract

BACKGROUND AND
PURPOSE: The usefulness of contrast-enhanced 3D T2-FLAIR MR imaging for the evaluation of leptomeningeal diseases has not been systematically investigated. The purpose of this study was to assess the value added by contrast-enhanced 3D T2-FLAIR and MPRAGE sequences to conventional postcontrast T1-weighted images in the evaluation of leptomeningeal diseases. We also undertook in vitro studies in attempts to understand the consequences of our patient study.
MATERIALS AND METHODS: Twelve patients with confirmed leptomeningeal diseases underwent postcontrast T1-weighted, MPRAGE, and 3D T2-FLAIR imaging at 3T. Two radiologists independently assessed the presence of additional information on postcontrast 3D MR images compared with postcontrast T1-weighted images. The effect of different Gd concentrations and flow velocities on the signal intensity on 3D T2-FLAIR images was investigated in vitro.
RESULTS: According to both reviewers, 3D T2-FLAIR images yielded significantly more information than did MPRAGE images (P < .05 and P < .01, respectively). In the in vitro study, 3D T2-FLAIR was more highly sensitive to low Gd concentrations and less sensitive to high Gd concentrations than were T1-weighted or MPRAGE sequences. On 3D T2-FLAIR sequences, at a flow velocity exceeding 1.0 cm/s, the signal intensity of blood-mimicking fluids at concentrations of 0 and 0.1 mmol/L was as low as at 1.3 mmol/L.
CONCLUSIONS: For the depiction of leptomeningeal diseases, postcontrast 3D T2-FLAIR provides more additional information than postcontrast MPRAGE imaging. The superiority of the 3D T2-FLAIR sequence is associated with its high sensitivity to flow.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20037130      PMCID: PMC7964192          DOI: 10.3174/ajnr.A1937

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  20 in total

1.  Suppression of cerebrospinal fluid and blood flow artifacts in FLAIR MR imaging with a single-slab three-dimensional pulse sequence: initial experience.

Authors:  D F Kallmes; F K Hui; J P Mugler
Journal:  Radiology       Date:  2001-10       Impact factor: 11.105

2.  Comparison of flow artifacts between 2D-FLAIR and 3D-FLAIR sequences at 3 T.

Authors:  Shinji Naganawa; Tokiko Koshikawa; Tatsuya Nakamura; Hisashi Kawai; Hiroshi Fukatsu; Takeo Ishigaki; Tomomi Komada; Katsuya Maruyama; Osamu Takizawa
Journal:  Eur Radiol       Date:  2004-06-19       Impact factor: 5.315

3.  Transthyretin-related familial amyloid polyneuropathy: evaluation of CSF enhancement on serial T1-weighted and fluid-attenuated inversion recovery images following intravenous contrast administration.

Authors:  Toshinori Hirai; Yukio Ando; Masayuki Yamura; Mika Kitajima; Yoshiko Hayashida; Yukunori Korogi; Taro Yamashita; Yasuyuki Yamashita
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

4.  Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.

Authors:  P J Strouse; M R Prince; T L Chenevert
Journal:  Radiology       Date:  1996-12       Impact factor: 11.105

5.  Time-dependent changes in image contrast in brain tumors after gadolinium-DTPA.

Authors:  W Schörner; M Laniado; H P Niendorf; C Schubert; R Felix
Journal:  AJNR Am J Neuroradiol       Date:  1986 Nov-Dec       Impact factor: 3.825

6.  MR imaging of leptomeningeal metastases: comparison of three sequences.

Authors:  Sanjay K Singh; Norman E Leeds; Lawrence E Ginsberg
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

7.  Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging.

Authors:  V P Mathews; K S Caldemeyer; M J Lowe; S L Greenspan; D M Weber; J L Ulmer
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

8.  FLAIR MR imaging for diagnosing intracranial meningeal carcinomatosis.

Authors:  K Tsuchiya; S Katase; A Yoshino; J Hachiya
Journal:  AJR Am J Roentgenol       Date:  2001-06       Impact factor: 3.959

9.  Visualization of intravenously administered contrast material in the CSF on fluid-attenuated inversion-recovery MR images: an in vitro and animal-model investigation.

Authors:  A C Mamourian; P J Hoopes; L D Lewis
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

10.  Contrast-enhanced fluid-attenuated inversion recovery imaging for leptomeningeal disease in children.

Authors:  Paul D Griffiths; Stuart C Coley; Charles A J Romanowski; Tim Hodgson; Iain D Wilkinson
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

View more
  36 in total

1.  MR diagnosis of facial neuritis: diagnostic performance of contrast-enhanced 3D-FLAIR technique compared with contrast-enhanced 3D-T1-fast-field echo with fat suppression.

Authors:  H K Lim; J H Lee; D Hyun; J W Park; J L Kim; H y Lee; S Park; J H Ahn; J H Baek; C G Choi
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-29       Impact factor: 3.825

Review 2.  European Society for Paediatric Oncology (SIOPE) MRI guidelines for imaging patients with central nervous system tumours.

Authors:  Shivaram Avula; Andrew Peet; Giovanni Morana; Paul Morgan; Monika Warmuth-Metz; Tim Jaspan
Journal:  Childs Nerv Syst       Date:  2021-05-10       Impact factor: 1.475

3.  Contrast-enhanced T2-FLAIR MR imaging in patients with uveitis.

Authors:  Diego A Herrera; Sergio Franco; Sebastián Bustamante; Sergio A Vargas; Martin Ochoa-Escudero; Arthur B Dublin; Miguel Cuevas
Journal:  Int Ophthalmol       Date:  2016-07-12       Impact factor: 2.031

4.  Contrast-enhanced modified 3D T1-weighted TSE black-blood imaging can improve detection of infectious and neoplastic meningitis.

Authors:  Nora Navina Sommer; Romina Pons Lucas; Eva Coppenrath; Hendrik Kooijman; Franziska Galiè; Nina Hesse; Wieland H Sommer; Karla M Treitl; Tobias Saam; Matthias F Froelich
Journal:  Eur Radiol       Date:  2019-11-05       Impact factor: 5.315

5.  Circumventricular organs of human brain visualized on post-contrast 3D fluid-attenuated inversion recovery imaging.

Authors:  Minako Azuma; Toshinori Hirai; Yoshihito Kadota; Zaw Aung Khant; Yohei Hattori; Mika Kitajima; Hiroyuki Uetani; Yasuyuki Yamashita
Journal:  Neuroradiology       Date:  2018-05-02       Impact factor: 2.804

6.  Effect of concentration of contrast agent on the inflow effect for measuring absolute perfusion by use of inversion recovery T₁-weighted TurboFLASH images.

Authors:  Mahmood Nazarpoor
Journal:  Radiol Phys Technol       Date:  2011-11-24

7.  Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases.

Authors:  Timothy J Kaufmann; Marion Smits; Jerrold Boxerman; Raymond Huang; Daniel P Barboriak; Michael Weller; Caroline Chung; Christina Tsien; Paul D Brown; Lalitha Shankar; Evanthia Galanis; Elizabeth Gerstner; Martin J van den Bent; Terry C Burns; Ian F Parney; Gavin Dunn; Priscilla K Brastianos; Nancy U Lin; Patrick Y Wen; Benjamin M Ellingson
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

8.  Usefulness of Contrast-Enhanced 3D-FLAIR MR Imaging for Differentiating Rathke Cleft Cyst from Cystic Craniopharyngioma.

Authors:  M Azuma; Z A Khant; M Kitajima; H Uetani; T Watanabe; K Yokogami; H Takeshima; T Hirai
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-19       Impact factor: 3.825

9.  Differentiation of Leptomeningeal and Vascular Enhancement on Post-contrast FLAIR MRI Sequence: Role in Early Detection of Infectious Meningitis.

Authors:  Armeen Ahmad; Sheenam Azad; Rajiv Azad
Journal:  J Clin Diagn Res       Date:  2015-01-01

Review 10.  Melanoma central nervous system metastases: current approaches, challenges, and opportunities.

Authors:  Justine V Cohen; Hussain Tawbi; Kim A Margolin; Ravi Amravadi; Marcus Bosenberg; Priscilla K Brastianos; Veronica L Chiang; John de Groot; Isabella C Glitza; Meenhard Herlyn; Sheri L Holmen; Lucia B Jilaveanu; Andrew Lassman; Stergios Moschos; Michael A Postow; Reena Thomas; John A Tsiouris; Patrick Wen; Richard M White; Timothy Turnham; Michael A Davies; Harriet M Kluger
Journal:  Pigment Cell Melanoma Res       Date:  2016-10-22       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.